CD274 and nasopharyngeal carcinoma: Non-keratinizing EBV+ NPC is characterized by a higher PD-L1 expression level and a pronounced lymphocytic infiltration in the tumor cell culture, rendering it a promising target for immunotherapy (Larbcharoensub et al., 2018; Outh-Gauer et al., 2018; Le et al., 2019).